Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

Phase: N/A Priority: Normal
NCT ID: NCT04627025 Org: User:
Start: 01/26/21 End: 02/22/24 Due: 02/22/25

Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC)

Phase: N/A Priority: Normal
NCT ID: NCT04964986 Org: User:
Start: 06/14/21 End: 06/06/23 Due: 06/06/24

Evaluation of Apraglutide on Gastric Emptying

Phase: N/A Priority: Normal
NCT ID: NCT05995704 Org: User:
Start: 03/02/23 End: 07/24/23 Due: 07/24/24

Proof-of-concept Trial of Apraglutide in GVHD

Phase: N/A Priority: Normal
NCT ID: NCT05415410 Org: User:
Start: 05/25/22 End: 12/17/24 Due: 12/17/25

Relative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation

Phase: N/A Priority: Normal
NCT ID: NCT06002555 Org: User:
Start: 05/23/23 End: 09/22/23 Due: 09/22/24

A Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT05706623 Org: User:
Start: 01/30/23 End: 04/04/23 Due: 04/04/24

Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT05018286 Org: User:
Start: 07/13/21 End: 10/30/27 Due: 10/30/28

Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.

Phase: N/A Priority: Normal
NCT ID: NCT04699032 Org: User:
Start: 12/08/20 End: 07/05/21 Due: 07/05/22